Blocking Interleukin-17 in Psoriasis: Real-world Experience from the PsoPlus Cohort.
Lisa SchotsRani SoenenBrigitte BlanquartDebby ThomasJo LambertPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
might rationalize clinical decision making, however there is need for standardized algorithms to corroborate its use.